Vice President, Pharmacovigilance & Risk Management

Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly impact critical pathways in allergic, inflammatory, and autoimmune diseases. As we advance toward potential commercialization of our lead asset, barzolvolimab, and continue to expand our late-stage pipeline, we are building a world-class organization capable of supporting both development and future commercial readiness. Our entrepreneurial culture empowers leaders to...